Industry Roundtable Discussion: Process Development for Complex Biologics: Bispecifics, Fusion Proteins and Antibody-Drug Conjugates

09 Mar 2027
Upstream Process Development & Optimisation
  • Addressing mispairing, aggregation, low titres and other molecule-specific challenges
  • Adapting established upstream process platforms for complex biologic formats
  • Integrating developability assessment and early process optimisation to improve manufacturability